Skip to main content
. 2021 Mar 12;10(6):1194. doi: 10.3390/jcm10061194

Table 2.

Cases and incidence rates 1 of confirmed COVID-19 that were admitted to the hospital, to intensive care unit or who died, according to the prior diagnosis of hypertension, cardiovascular disease, cerebrovascular disease or chronic kidney disease.

Hospitalization Severe Cases 2 ICU Admission Deaths
Study population N 1106 176 117 97
Rate 1 260 41 28 23
Persons with HT N 354 85 52 55
Rate 1 496 119 73 77
Persons without HT N 752 91 65 42
Rate 1 213 26 18 12
HT vs all others RR (95% CI) 2.33 (2.06–2.65) 4.63 (3.44–6.22) 3.96 (2.75–5.71) 6.49 (4.34–9.70)
Persons with CVD N 188 51 25 41
Rate 1 606 164 81 132
Persons without CVD N 918 125 92 56
Rate 1 233 32 23 14
CVD vs all others RR (95% CI) 2.60 (2.22–3.04) 5.18 (3.74–7.18) 3.45 (2.22–5.37) 9.30 (6.22–13.91)
Persons with CBVD N 46 16 5 16
Rate 1 814 283 89 283
Persons without CBVD N 1060 160 112 81
Rate 1 253 38 27 19
CBVD vs all others RR (95% CI) 3.22 (2.40–4.33) 7.42 (4.44–12.41) 3.31 (1.35–8.11) 14.66 (8.57–25.06)
Persons with CKD N 89 27 10 21
Rate 1 899 273 101 212
Persons without CKD N 1017 149 107 76
Rate 1 245 36 26 18
CKD vs all others RR (95% CI) 3.67 (2.95–4.55) 7.59 (5.04–11.44) 3.92 (2.05–7.49) 11.58 (7.14–18.77)

1 Rates are expressed as cases per 100,000 persons. 2 Severe cases include patients who were admitted to intensive care unit or died. ICU, intensive care unit; RR, relative risk; CI, confidence interval; HT, hypertension; CVD, cardiovascular disease; CBVD, cerebrovascular disease; CKD, chronic kidney disease.